Cell Therapeutics Signs Deal With Norvatis

| 19 Sep 2006 | Posts | 1,028 views

Cell Therapeutics (CTIC) has signed a worldwide licensing deal with Norvartis worth US$285M. This agreement will see Norvatis assisting in the development and commercialisation of Cell Therapeutics’ flagship drug, XYOTAX. The amount includes US$15M equity investment in the drug development company as well.

Cell Therapeutics traded up 13 cents or 6.67% on Monday to $2.08.

Technorati Tags: , , , , , , , ,


Related posts:

:, , Subscribe

Leave a Reply


Be Good

View Teng-Yan Loke's profile on LinkedIn

The Hunger Site

Counter visits since 16 Sep 2006

Technology Blogs - BlogCatalog Blog Directory